Spanish private university researching oral bone regeneration with stem cells and 3D biomaterials, and multilingual education in Catalan school contexts.
Universitat Internacional de Catalunya (UIC Barcelona) is a private Spanish university conducting research across two distinct faculties: oral and maxillofacial health sciences, and multilingual education. In health research, they contribute clinical trial expertise and work at the intersection of dental surgery, stem cell biology, and 3D-printed biomaterials for bone reconstruction. In education research, they lead applied linguistics projects investigating how children acquire multiple languages simultaneously in Catalan school settings. These two tracks reflect the university's multi-faculty structure rather than a unified research agenda.
Contributed clinical and research capacity to MAXIBONE (2018–2022), a personalised bone regeneration project combining autologous mesenchymal stem cells with 3D-printed biomaterials for vertical bone defects.
Coordinated MultiCat (2021–2023), a study of multilingual development in Catalonia examining grammar, vocabulary, literacy, CLIL, and EFL acquisition across societal and foreign language contexts.
MAXIBONE involved a randomised clinical trial design, indicating capacity to run and report structured clinical studies in dental and oral surgery settings.
MultiCat keywords include CLIL and EFL, pointing to expertise in researching immersive bilingual teaching methods common in Catalan and broader European school systems.
In their earliest H2020 engagement (2018), UIC Barcelona entered European research through health sciences — specifically oral surgery and regenerative medicine, joining a consortium focused on stem-cell-based bone reconstruction. By 2021 their second project represented a complete thematic break: they moved into multilingual education research and took the coordinator role, suggesting a different internal team had by then built enough capacity to lead an EU project independently. There is no visible convergence between the two tracks, which points to parallel but separate research groups rather than an institution with a unified research direction.
UIC Barcelona appears to be expanding its EU project footprint across faculties simultaneously — a future collaborator should expect to engage with a specific department (health sciences or education) rather than the institution as a whole, as the two tracks share no evident overlap.
UIC Barcelona has experience on both sides of the table: joining as a participant in a large health sciences consortium (MAXIBONE) and leading a smaller linguistics project as coordinator (MultiCat). With 13 unique partners across just two projects, their consortium experience is limited but balanced between followership and leadership. This suggests they can adapt their role to the project type, though their track record is too short to characterise a dominant style.
UIC Barcelona has collaborated with 13 unique organisations across 6 countries, spread across health and education consortia with no apparent overlap between the two partner networks. Their geographic footprint is European in scope but thin in depth given the small project count.
UIC Barcelona occupies an unusual niche as a private Spanish university with active EU research in both clinical health sciences and multilingual education — two areas that rarely appear together in the same institutional profile. Within health, their specific angle on maxillofacial bone regeneration using stem cells and 3D printing is a differentiator from generic medical universities. For education consortia working on multilingual or CLIL research in southern Europe, their Catalan context — a natural multilingual laboratory — is a tangible asset.
